🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
9.95
-0.62 (-5.87%)
At close: Nov 20, 2026, 4:00 PM EST
10.07
+0.12 (1.21%)
After-hours: Nov 20, 2026, 7:54 PM EST

Summit Therapeutics Statistics

Total Valuation

SMMT has a market cap or net worth of $7.96 billion. The enterprise value is $7.35 billion.

Market Cap7.96B
Enterprise Value 7.35B

Important Dates

The last earnings date was Wednesday, November 4, 2026, after market close.

Earnings Date Nov 4, 2026
Ex-Dividend Date n/a

Share Statistics

SMMT has 799.76 million shares outstanding. The number of shares has increased by 5.30% in one year.

Current Share Class 799.76M
Shares Outstanding 799.76M
Shares Change (YoY) +5.30%
Shares Change (QoQ) +2.57%
Owned by Insiders (%) 76.77%
Owned by Institutions (%) 17.17%
Float 153.70M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 328.28
PB Ratio 14.09
P/TBV Ratio 14.14
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.99, with a Debt / Equity ratio of 0.04.

Current Ratio 5.99
Quick Ratio 5.71
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -220.01% and return on invested capital (ROIC) is -136.65%.

Return on Equity (ROE) -220.01%
Return on Assets (ROA) -174.46%
Return on Invested Capital (ROIC) -136.65%
Return on Capital Employed (ROCE) -146.79%
Weighted Average Cost of Capital (WACC) -4.10%
Revenue Per Employee n/a
Profits Per Employee -$3.14M
Employee Count265
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -39.92% in the last 52 weeks. The beta is -1.52, so SMMT's price volatility has been lower than the market average.

Beta (5Y) -1.52
52-Week Price Change -39.92%
50-Day Moving Average 15.74
200-Day Moving Average 16.06
Relative Strength Index (RSI) 30.28
Average Volume (20 Days) 6,885,536

Short Selling Information

The latest short interest is 42.26 million, so 26.67% of the outstanding shares have been sold short.

Short Interest 42.26M
Short Previous Month 40.90M
Short % of Shares Out 26.67%
Short % of Float n/a
Short Ratio (days to cover) 7.56

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -855.24M
Pretax Income -832.68M
Net Income -832.68M
EBITDA -855.03M
EBIT -855.24M
Earnings Per Share (EPS) -$1.07
Full Income Statement

Balance Sheet

The company has $629.79 million in cash and $19.98 million in debt, with a net cash position of $609.81 million or $0.76 per share.

Cash & Cash Equivalents 629.79M
Total Debt 19.98M
Net Cash 609.81M
Net Cash Per Share $0.76
Equity (Book Value) 564.68M
Book Value Per Share 0.71
Working Capital 550.50M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$525.17 million and capital expenditures -$1.71 million, giving a free cash flow of -$526.88 million.

Operating Cash Flow -525.17M
Capital Expenditures -1.71M
Depreciation & Amortization 217,000
Net Borrowing n/a
Free Cash Flow -526.88M
FCF Per Share -$0.66
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SMMT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -5.30%
Shareholder Yield -5.30%
Earnings Yield -10.73%
FCF Yield -6.62%
Dividend Details

Analyst Forecast

The average price target for SMMT is $28.77, which is 189.15% higher than the current price. The consensus rating is "Buy".

Price Target $28.77
Price Target Difference 189.15%
Analyst Consensus Buy
Analyst Count 17
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2